Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

FDA Public Hearing on Homeopathic Product Regulation: April 20 - 21, 2015

Wednesday, March 25, 2015   (0 Comments)
Posted by: IACP
Share |

Homeopathic Product Regulation: Evaluating FDA’s Regulatory Framework After a Quarter-Century
The Food and Drug Administration (FDA) is announcing a public hearing to obtain information and comments from stakeholders about the current use of human drug and biological products labeled as homeopathic, as well as the Agency’s regulatory framework for such products. These products include prescription drugs and biological products labeled as homeopathic and over-the-counter (OTC) drugs labeled as homeopathic. FDA is seeking participants for the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, and industry. FDA is seeking input on a number of specific questions, but is interested in any other pertinent information participants would like to share.

FDA Public Hearing on Homeopathic Product Regulation: April 20 - 21, 2015

 

Please click here for more information.


Association Management Software Powered by YourMembership  ::  Legal